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Abstract
Background/objective: Kaposi sarcoma (KS) is now the most frequently reported malignant skin tumour
in some areas of Africa and was endemic in Africa before the advent of the human immunodeficiency
virus (HIV) infection. The prevalence has increased with the emergence of HIV infection. The objective
of this report is to describe the frequency, current clinical pattern, and anatomic distribution of KS in
Calabar, south-eastern Nigeria and compare this with total malignant skin tumour.
Method: All the patients with histologic diagnosis of KS presenting to the University of Calabar Teaching
Hospital from January 2005 and December 2006 were analyzed as part of the wider study of malignant
skin tumorus. Diagnosis of HIV was based upon enzyme linked immunosorbent assay.
Results: In our study, there were 11 patients (7 males and 4 females), with a male: female ratio of 1.75:
1. This was the commonest malignant skin tumor (38%) followed by squamous cell carcinoma (SCC)
(34.5%) and the age ranged from 21 – 60 years (mean 42.9years). Nine patients (81.8%) were HIV
positive including the 4 females (age ranged from 21 -45 years) and 2(18.2%) HIV negative, aged 59 and
60years. The lower limb was the commonest site (50%). Atypical lesions involved the eyelids/ nose and
penis.
Conclusion: KS is now the commonest malignant skin tumour in our region with the HIV related KS as
the commonest clinical type. Successful prevention and treatment of HIV infection would reduce the
prevalence of this tumour.
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Résumé
Contexte: Le sarcome de Kaposi est à l’heure actuelle la plus fréquente des tumeurs malignes cutanées
dans certaines zones d’Afrique. Il sévissait à l’état endémique avant l’avènement de l’infection par le
virus de l’immunodéficience humaine (VIH). La prévalence s’est accrue avec l’émergence l’infection par
le VIH. L’objectif de ce travail est de décrire la fréquence, le mode de présentation clinique usuel, et la
distribution anatomique du sarcome de Kaposi à Calabar dans le Sud-est du Nigeria et de procéder a
une comparaison avec l’ensemble des tumeurs malignes cutanées.
Méthode: Tous les patients ayant un sarcome de Kaposi confirme histologiquement et ayant consulte
au Centre Hospitalier Universitaire de Calabar de janvier 2005 a décembre 2006 ont été considéré
comme un échantillon de la population des tumeurs malignes cutanées. Le diagnostic de l’infection VIH
était base sur la technique ELISA.
Résultats: Notre étude comptait 11 patients (7 hommes et 4 femmes), avec un sexe ratio homme
femme de 1,75. Il s’agissait de la tumeur maligne cutanée la plus fréquente (38%) suivi par le carcinome
a cellule squameuses (34,5%). L’âge variait de 21 a 60 ans pour une moyenne de 42,9 ans. Neuf patients
(81,8%) était séropositifs y compris les 4 femmes 9age allant de 21 à 45 ans). Deux patients âgés
respectivement de 59 et de 60 ans étaient séronégatifs. La localisation la plus fréquente était le
membre inferieur (50%) ; les lésions atypiques concernaient les paupières, le nez et le pénis.
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Conclusion: Le sarcome de Kaposi est de nos jours la plus fréquente des tumeurs malignes cutanées
dans notre région et sa forme associée au VIH est le type clinique le plus courant. Une prévention
efficace et le traitement de l’infection VIH pourrait réduire la prévalence de cette tumeur
Mots clés: Sarcome de Kaposi, mode de présentation, VIH
Introduction
Kaposi sarcoma is now the most frequently reported
malignant skin tumour in some areas of Africa and
was endemic in Africa even before the advent of the
human immunodeficiency virus (HIV).
1,2
There are 4
clinical types of KS: Classic, African (endemic),
immunosuppressive (transplant) associated and
Acquired immuno-deficiency syndrome (AIDS)
associated KS with identical histological features.
3
Since the emergence of HIV infection there has been
a steady increase in the prevalence of KS worldwide.
4
In Nigeria, with an adult seroprevalence ratio of
5.8%, this disease is a major cause of morbidity and
mortality.
5
In an earlier study in this center, there
was no convincing evidence that the disease was
associated with HIV infection.
6
This is a report of the
changing trend of KS in the same center.
Patient and Methods
Patients who had histologic diagnosis of Kaposi
sarcoma in the University of Calabar Teaching
Hospital (UCTH), Calabar from January 2005 –
December 2006 as part of our prospective study of
malignant skin tumours were studied. This was
compared with KS seen from 2000 – 2004 and total
malignant skin tumour (2005-2006). Serology test for
HIV antibodies were performed using the enzyme
linked immunosorbent assay (ELISA).
Results
There were 11 patients (7males and 4females) with a
M: F ratio of 1.75: 1, this accounted for 38% of
malignant skin tumours seen during this study
period. Squamous cell carcinoma (SCC) ranked 2nd
with 10 patients (34.5%) (Table 1). In an earlier study
of malignant skin tumours in this hospital (2000 –
2004), KS ranked 2
nd
(27%) following SCC (37%). The
ages ranged from 21 – 60 years, (mean 42.9years)
(Table 2). Nine patients (81.8%) were HIV positive,
their ages ranged from 21 – 45years and 2(18.2%)
HIV negative, aged 59 and 60years. All the patients
were heterosexuals who presented late in hospital
after prior traditional herbal treatment for periods
that ranged from six months and 10 years.
Single 3(27.3%) and multiple 8(72.7%) sites were
involved in various combinations resulting in the
lower limb as the commonest site 8(50%). Others
were the face; 2(12.5%), (Figure 1), trunk, 2(12.5%)
and lymph node 2(12.5%), upper limb in a patient
and the penis in another, (Figure 2) in a patient each
(Table 3).
The two patients (18.2%) with African KS received
systemic chemotherapy (vincristine) with regression
of nodules, follow-up were 12 and 18months. Four
patients (36.3%) serology positive were lost to
follow-up after histologic diagnosis. Four patients
(36.3%) serology positive had antiretroviral therapy
(ART) with systemic chemotherapy (vincristine). Out
of these two were still being observed in the
outpatient with regression of the nodules. Follow-up
has been for 6 and 8months. Two patients with
localized lesions, eyelid and chronic toe ulcer with
deformity had excision and amputation respectively.
There was one hospital mortality in a male HIV
positive patient. The fungating lesions were dressed
with honey and antibiotics administered based on
sensitivity, the common isolates were Staphylococcus
aureus pseudomonas and proteus.
Table 1. Skin cancers in 29 patients in Calabar, South-eastern Nigeria
Tumour type Sex Total (%)
M F
Kaposi sarcoma 7 4 11 (37.9)
Squamous cell carcinoma 6 4 10 (34.5)
Malignant melanoma 2 2 4 (13.8)
Metastatic skin cancer 1 1 2 (6.9)
Basal cell carcinoma - 1 1 (3.4)
Malignant adnexal tumor - 1 1 (3.4)
Total 16 13 29 (100)
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Table 2. Age and sex distribution of 11 patients with Kaposi’s sarcoma
Age (years) Sex Total (%)
M F
≤10 - - -
11-20 - - -
21-30 - 2 2 (18.2)
31-40 2 1 3 (27.3)
41-50 2 - 2 (18.2)
51-60 3 1 4 (36.3)
Total 7 4 11 (100)
Age range: 21 – 60years (mean 42.9years)
Table 3. Anatomical distribution of Kaposi sarcoma in 11 patients
Region Seropositive Seronegative Total
Face (Eyelid/ nose) 2 - 2
Upper limb 1 - 1
Trunk 2 - 2
External genitalia (penis) 1 - 1
Lymph node (inguinal) 2 - 2
Lower limb 6 2 8
Figure 1. Kaposi sarcoma involving the eyelids
and nose
Figure 2. Kaposi sarcoma involving the penis
Discussion
We report an increased prevalence of KS in our
region. It was the commonest malignant skin tumour
that accounted for 38% of total malignant skin
tumours, SCC ranked 2nd (34.5%) in this study
compared to a previous one in this center where KS
ranked 2nd (27%) following SCC (37%).
7
In Kano –
northern Nigeria, KS was the 4th most prevalent
malignant skin tumour (8%)
8
and in Maiduguri –
northern Nigeria 16%.
9
Our findings showed that KS was HIV-related in
81.8% while African (endemic) KS was recorded in
18.2% of patients. The cases of KS documented by
histology do not represent all the cases of KS seen as
most patients with clinical suspicion did not have
histopathologic diagnosis. However, this was at
variance with an earlier publication from this center
which suggested that KS was not related to HIV
infection.
6
This current clinical pattern of KS seen is in
keeping with reports from Nigeria and other African
countries affected by HIV epidemic.
5, 10
Kaposi sarcoma was predominantly a disease of
men in both the black and white.
3
However, in our
study there were 7 males and 4 females (male:
female 1.75: 1). Onunu et al in Benin – Nigeria
reported a M: F ratio of 1.6: 1.
5
This is contrary to
previous Nigerian studies that reported the
occurrence of KS exclusively in men.
6
It is also note
worthy that all the females in this study were HIV
positive and one presented with atypical lesions
involving the eyelids and nose (Figure 1).
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It is noteworthy that with the advent of HIV
infection more females were involved contrary to
previous studies with mainly endemic KS as the
clinical type that involved mainly men, Wabinga et al
reported in endemic KS a M: F ratio of 15: 1.
11
Atypical lesions (Figures 1 and 2) should arouse the
suspicion of HIV.
The HIV related KS in this study affected young
adults aged 21 – 45years whereas the endemic KS
were aged 59 and 60years. HIV related KS has been
known to affect younger patients than the other
clinical types.
12
Ignorance, poverty and socio-cultural beliefs were
underlying issues as most patients presented late
after prior traditional medical treatment and there
after some were lost to follow-up for fear of
stigmatization.
In conclusion, this study demonstrated the
changing trend of KS in our region. It revealed that
HIV related KS is now more common especially in
young adults than endemic KS and that atypical
lesions should arouse the suspicion of HIV infection.
KS is more likely to be seen in women with HIV
positivity. Successful prevention and treatment of
HIV infection would result in a decline in the
prevalence of this tumour with improved outcome.
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